Background: Calorie restriction (CR) influences aging processes and extends average and maximal life spans. The CALERIE 2 (Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy Phase 2) study was the first randomized clinical trial to examine the metabolic and psychological effects of CR in nonobese humans.Objective: We conducted a 2-y follow-up study of adults who underwent 2 y of CR or ad libitum (control) consumption and determined whether weight loss and acquired behaviors persisted after the study ended when participants determined their own lifestyle behaviors.Design: In this prospective, longitudinal study, we assessed differences in weight, body composition, psychological function, and energy expenditure in 39 nonobese [body mass index (in kg/m2): 22-28] men and women (25% CR: n = 24; control: n = 15) 12 and 24 mo after they completed the CALERIE 2 study at Pennington Biomedical. Results: Of 39 participants who were in the follow-up study, 29 subjects (CR: n = 18; control: n = 11) completed all visits at follow-up months 12 and 24. After the CR intervention, a mean ± SEM weight loss of 9.0 ± 0.6 kg was observed in the CR group, in which only 54% of the weight was regained 2 y later. Despite such a regain, weight, the percentage of body fat, and fat mass remained significantly reduced from baseline throughout follow-up and remained significantly less than in the control group (P < 0.05). At follow-up, the CR group retained higher degrees of dietary restraint and avoidance of certain foods. Conclusion: After a 2-y intensive CR intervention, ∼50% of CR-induced weight loss was maintained 2 y later, which was probably the result of lasting effects on acquired behaviors and dietary restraint. This trial was registered at clinicaltrials.gov as NCT00943215.
RCT Entities:
Background: Calorie restriction (CR) influences aging processes and extends average and maximal life spans. The CALERIE 2 (Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy Phase 2) study was the first randomized clinical trial to examine the metabolic and psychological effects of CR in nonobese humans.Objective: We conducted a 2-y follow-up study of adults who underwent 2 y of CR or ad libitum (control) consumption and determined whether weight loss and acquired behaviors persisted after the study ended when participants determined their own lifestyle behaviors.Design: In this prospective, longitudinal study, we assessed differences in weight, body composition, psychological function, and energy expenditure in 39 nonobese [body mass index (in kg/m2): 22-28] men and women (25% CR: n = 24; control: n = 15) 12 and 24 mo after they completed the CALERIE 2 study at Pennington Biomedical. Results: Of 39 participants who were in the follow-up study, 29 subjects (CR: n = 18; control: n = 11) completed all visits at follow-up months 12 and 24. After the CR intervention, a mean ± SEM weight loss of 9.0 ± 0.6 kg was observed in the CR group, in which only 54% of the weight was regained 2 y later. Despite such a regain, weight, the percentage of body fat, and fat mass remained significantly reduced from baseline throughout follow-up and remained significantly less than in the control group (P < 0.05). At follow-up, the CR group retained higher degrees of dietary restraint and avoidance of certain foods. Conclusion: After a 2-y intensive CR intervention, ∼50% of CR-induced weight loss was maintained 2 y later, which was probably the result of lasting effects on acquired behaviors and dietary restraint. This trial was registered at clinicaltrials.gov as NCT00943215.
Authors: Sai Krupa Das; Cheryl H Gilhooly; Julie K Golden; Anastassios G Pittas; Paul J Fuss; Rachel A Cheatham; Stephanie Tyler; Michelle Tsay; Megan A McCrory; Alice H Lichtenstein; Gerard E Dallal; Chhanda Dutta; Manjushri V Bhapkar; James P Delany; Edward Saltzman; Susan B Roberts Journal: Am J Clin Nutr Date: 2007-04 Impact factor: 7.045
Authors: D Enette Larson-Meyer; Leonie K Heilbronn; Leanne M Redman; Bradley R Newcomer; Madlyn I Frisard; Steve Anton; Steven R Smith; Anthony Alfonso; Eric Ravussin Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112
Authors: Susan B Racette; Edward P Weiss; Dennis T Villareal; Hassan Arif; Karen Steger-May; Kenneth B Schechtman; Luigi Fontana; Samuel Klein; John O Holloszy Journal: J Gerontol A Biol Sci Med Sci Date: 2006-09 Impact factor: 6.053
Authors: T M Stewart; M Bhapkar; S Das; K Galan; C K Martin; L McAdams; C Pieper; L Redman; S Roberts; R I Stein; J Rochon; D A Williamson Journal: Contemp Clin Trials Date: 2012-09-05 Impact factor: 2.226
Authors: Donald A Williamson; Corby K Martin; Stephen D Anton; Emily York-Crowe; Hongmei Han; Leanne Redman; Eric Ravussin Journal: Health Psychol Date: 2008-01 Impact factor: 4.267
Authors: Catarina L Nunes; Filipe Jesus; Ruben Francisco; Catarina N Matias; Moonseong Heo; Steven B Heymsfield; Anja Bosy-Westphal; Luis B Sardinha; Paulo Martins; Cláudia S Minderico; Analiza M Silva Journal: Eur J Nutr Date: 2021-11-27 Impact factor: 5.614
Authors: Catarina L Nunes; Filipe Jesus; Ruben Francisco; Mark Hopkins; Luís B Sardinha; Paulo Martins; Cláudia S Minderico; Analiza M Silva Journal: Eur J Nutr Date: 2022-07-14 Impact factor: 4.865
Authors: Natalie M Papini; Rachel N S Foster; Nanette V Lopez; Lauren T Ptomey; Stephen D Herrmann; Joseph E Donnelly Journal: BMC Psychol Date: 2022-04-15